Feedback / Questions
onvansertib (PCM-075) - Cardiff Oncology
https://www.globenewswire.com/news-release/2026/04/17/3276475/0/en/cardiff-oncology-presents-preclinical-data-on-its-plk1-inhibitor-onvansertib-in-combination-with-a-her2-targeted-adc-at-the-2026-aacr-annual-meeting.html
Apr 17, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next